Africa (WHO region) vs North Macedonia: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
North Macedonia
100.0%
in 2020
Africa (WHO region) rank
2nd
North Macedonia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- North Macedonia
How they compare
North Macedonia currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
Across all 6 years both countries report, North Macedonia has been ahead every year.
Africa (WHO region) ranks 2nd and North Macedonia ranks 1st of 11 groups.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.5% | 100.0% | 70.5% | North Macedonia |
| 2010s | 86.7% | 100.0% | 13.3% | North Macedonia |
| 2020s | 92.0% | 100.0% | 8.0% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or North Macedonia?
- North Macedonia, at 100.0% against 96.0% in Africa (WHO region) as of 2020.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and North Macedonia?
- 4.0%, with North Macedonia ahead.
- How many years of comparable data are there for Africa (WHO region) and North Macedonia?
- 6 years are reported by both, from 2005 to 2020.
- How do Africa (WHO region) and North Macedonia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and North Macedonia ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.